LAVA Therapeutics NV Adjustments For Share-based Payments
LAVA Therapeutics NV reported Adjustments For Share-based Payments of $5.04 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-20.
Discontinued › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2024-03-20
| Period end | Adjustments For Share-based Payments 12 month | Adjustments For Share-based Payments 12 month as first filed |
|---|---|---|
| 2023-12-31 | $5.04M 20-F · filed 2024-03-20 | |
| 2022-12-31 | $4.11M 20-F · filed 2024-03-20 | |
| 2021-12-31 | $3.91M 20-F · filed 2024-03-20 | $4.30M 20-F · filed 2022-03-24 |
| 2020-12-31 | $557.00K 20-F · filed 2023-04-11 | |
| 2019-12-31 | $192.00K 20-F/A · filed 2022-12-23 |